Hypothyroidism Affects 58.7% of Indian Type 2 Diabetes Patients, Especially Females, Underscoring Screening Need
Background
The coexistence of Type 2 Diabetes Mellitus (T2DM) and thyroid dysfunction is a well-recognized clinical challenge, with both hyperthyroidism and hypothyroidism being more prevalent in diabetic individuals compared to the general population. Uncontrolled thyroid hormone levels can significantly impact metabolic pathways, potentially exacerbating insulin resistance, altering glucose metabolism, and complicating diabetes management. Despite this known association, the specific prevalence of hypothyroidism and its direct impact on glycaemic control and associated comorbidities within the Indian T2DM population remains an area requiring more focused investigation, guiding targeted screening strategies.
Study Design
This cross-sectional study enrolled 218 patients with Type 2 Diabetes Mellitus (T2DM) attending a tertiary care center in India. Researchers collected patient demographics and data on comorbidities. Blood samples were analyzed to measure glycosylated haemoglobin (HbA1c) levels, a key indicator of long-term glycaemic control, and thyroid-stimulating hormone (TSH) levels to assess thyroid function. Patients were then categorized into euthyroid, hyperthyroid, or hypothyroid groups based on their TSH levels. A subsequent sub-analysis specifically compared demographic and biochemical parameters between the euthyroid and hypothyroid patient cohorts.
Results
The study revealed a remarkably high prevalence of hypothyroidism, affecting 58.7% of the 218 patients with Type 2 Diabetes Mellitus included in the cohort. This prevalence was notably higher among females, aligning with general epidemiological trends for thyroid disorders. The mean age of the patient population was 57.6 ± 11.1 years, with a slight female predominance (54.1%). > Despite the high prevalence, the study found no statistically significant differences in comorbidities or overall HbA1c levels when comparing euthyroid and hypothyroid patients. However, a nuanced finding emerged: among patients with HbA1c levels of ≥6.4%, women exhibited a higher prevalence of hypothyroidism, suggesting a potential interaction in poorly controlled female diabetics. The lack of a direct impact on average HbA1c across the entire cohort indicates that while prevalent, hypothyroidism's effect on broad glycaemic control might be complex or require further stratification.
Key Findings
- Hypothyroidism prevalence was 58.7% among Indian Type 2 Diabetes Mellitus patients.
- Hypothyroidism was more prevalent in females within the T2DM cohort.
- No significant differences in comorbidities or overall
HbA1clevels were observed between euthyroid and hypothyroid patients. - Among patients with
HbA1c ≥6.4%, women showed a higher prevalence of hypothyroidism.
Why It Matters
This study highlights a critical need for routine thyroid function screening in patients with Type 2 Diabetes Mellitus, particularly in the Indian population and especially among females. Identifying and managing hypothyroidism early could prevent potential long-term complications and optimize overall diabetes care, even if a direct impact on average HbA1c wasn't observed in this specific cohort. While the study didn't show significant differences in HbA1c or comorbidities between euthyroid and hypothyroid groups, the sheer prevalence of 58.7% suggests that many T2DM patients may have an undiagnosed or suboptimally managed co-condition. This finding reinforces existing clinical guidelines that advocate for comprehensive metabolic evaluations in diabetic patients, ensuring that thyroid dysfunction, a treatable condition, does not silently contribute to patient morbidity or complicate future treatment strategies.